Singleton, K. W., Porter, A. B., Hu, L. S., Johnston, S. K., Bond, K. M., Rickertsen, C. R., . . . Swanson, K. R. (2020). Days gained response discriminates treatment response in patients with recurrent glioblastoma receiving bevacizumab-based therapies. Neurooncol Adv.
Παραπομπή Chicago StyleSingleton, Kyle W., et al. "Days Gained Response Discriminates Treatment Response in Patients With Recurrent Glioblastoma Receiving Bevacizumab-based Therapies." Neurooncol Adv 2020.
Παραπομπή MLASingleton, Kyle W., et al. "Days Gained Response Discriminates Treatment Response in Patients With Recurrent Glioblastoma Receiving Bevacizumab-based Therapies." Neurooncol Adv 2020.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.